[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-346349-en":3,"detail-sidebar-cat-0-en-105":51,"doc-seo-346349-105":98},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},346349,687197100911,"Himbo","https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697",8,"Research & Report","Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy - the AFSOSUnicancer QUALIOR randomized phase 2 study","Background: The QUALIOR phase 2 multicenter trial assessed the feasibility of a home-based supervised physical exercise program (SPEP) in metastatic cancer patients receiving oral targeted therapies. Methods: Patients were randomized 2:1 to a 3-month home-based SPEP with an in-home coach or to recommended adapted physical exercises using a booklet. Feasibility was defined by completing at least 50% of planned sessions; fatigue and pain were secondary outcomes using VAS. Results: In 112 patients, 61% completed at least 50%. Fatigue decreased in the SPEP group and high VAS fatigue at 3 months was lower than control. Conclusions: Home-based SPEP with an at-home coach was feasible and may mitigate treatment-related fatigue.","Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOSUnicancer QUALIOR randomized phase 2 study  \nFlorence Joly1, *,, Claudia Lefeuvre-Plesse2, Emilie Charton3, Carole Helissey4, Franck Priou5, Laetitia Stefani6, Victor Simmet7, Elise Bonnet8,, Nathalie Meneveau9, Nathalie Houede10, Sébastien Salas11, Emmanuelle Bourbouloux12, Soazig Nenan13, Isabelle Rieger13, Jean-Marc Descotes14, Amélie Anota3  \n1Department of Medical Oncology Centre François Baclesse, CAEN, Inserm U1086 “Anticipe” – University Unicaen, Caen 14790, France 2Department of Medical Oncology Centre Eugène Marquis, Rennes 35000, France  \n3Department of Clinical Research and Innovation, Centre Léon Bérard, Lyon 69000, France  \n4Department of Medical Oncology, HIA Begin, St Mande 14160, France 5Department of Medical Oncology, CHD Vendée, La Roche Sur Yon 85000, France 6Department of Medical Oncology CH Annecy Genevois, Pringy 74370, France 7Department of Medical Oncology CH de Cholet, Cholet 49309, France 8Department of Medical Oncology Institute Daniel Hollard, Grenoble 38000, France 9Department of Medical Oncology CHRU de Besançon, Besancon 26056, France  \n10Department of Medical Oncology CH Nîmes, Institut de Cancérologie du Gard, Nimes 30900, France  \n11Department of Medical Oncology CHU La Timone, Marseille 13000, France 12Department of Médical ICO René Gauducheau, Saint Herblain 44162, France 13Unicancer, Paris 75000, France  \n14Sport et Cancer, Neuilly Sur Seine 92200, France  \n*Corresponding author. Florence Joly, Department of Medical Oncology Centre François Baclesse, CAEN; Inserm U1086 “Anticipe” – University Unicaen, 3 avenye du general Harris, BP 45026, 14076 Caen, France ([f.joly@baclesse.unicancer.fr](f.joly@baclesse.unicancer.fr)) .  \nAbstract  \nBackground: QUALIOR-phase 2 multicenter trial explored the feasibility of a home-based supervised physical exercise program (SPEP) in metastatic cancer patients receiving oral targeted therapies.  \nMethods: Patients with metastatic cancers receiving oral targeted therapies were randomized (2:1) to a 3-month home-based SPEP (with a coach at home) or recommended adapted physical exercises (booklet) . Primary endpoint was feasibility defined as the rate of patients who performed at least 50% of the theoretically planned sessions in the SPEP arm. Main secondary endpoints were fatigue and pain evaluated by visual analogue scales (VAS) during the program.  \nResults: Among 112 patients, 74 and 38 were included in the SPEP and control arms, respectively. Median age was 59 (range: 31-83) years and the majority of patients were women. Main primary tumor location was breast (57%) and kidney (16%) . Thirty-three (30%) patients were treated with anti–angiogenic tyrosine kinase inhibitors, and 53 (47%) received epidermal growth factor receptor or cell cycle inhibitors. Forty-five (61%) patients performed at least 50% of the SPEP. Median fatigue decreased from 4 to 3 (range: 0-10) after 3 months in the SPEP group with maintain of pain control. The percentage of patients with high level VAS of fatigue at 3 months was lower in SPEP arm than in the control arm (27% vs. 62%, P = .004) .  \nConclusions: QUALIOR showed that SPEP with a coach at home was feasible in patients with metastatic cancers treated with oral targeted therapies. This program could mitigate the fatigue induced by oral targeted therapies.  \nKey words: metastatic cancers; home-based supervised physical exercise program (SPEP); oral targeted therapies.  \nIntroduction  \nOral targeted therapies are increasingly being prescribed to treat patients with metastatic cancers. They are widely used for a mixed range of cancers including breast, lung, skin, kidney, and others. Among the side effects caused by oral targeted therapies,  \nfatigue is the most frequently reported. Described as more severe, more persistent and debilitating than usual tiredness, cancer-related fatigue induced by oral targeted therapies starts as ","cbCaikebxHG59sye","https://ap.wps.com/l/cbCaikebxHG59sye","pdf",600495,10,1,9,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Implications for practice","[{\"question\":\"What was the primary endpoint in the QUALIOR phase 2 study?\",\"answer\":\"Feasibility was defined as the proportion of patients who performed at least 50% of the theoretically planned sessions in the SPEP arm.\"},{\"question\":\"How were participants assigned in the trial?\",\"answer\":\"Patients with metastatic cancers receiving oral targeted therapies were randomized 2:1 to either a 3-month home-based SPEP with an in-home coach or adapted physical exercises recommended via a booklet.\"},{\"question\":\"What outcomes were used to assess fatigue and pain?\",\"answer\":\"Fatigue and pain were evaluated using visual analogue scales (VAS) during the program.\"}]","Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy - the AFSOSUnicancer QUALIOR randomized phase 2 study | PDF",1790061015,23,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/faad9c3c46c4bc269f94a8a99c9fb9a3.webp",983,1291,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e0875c1f9464ef82c9a3cbd2924b873.webp",982,1290,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f81285dcb3c044803c7d8c51f3c71d6e.webp",981,1289,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dee95719edcac0af3a81d6a9c9893f65.webp",980,1287,{"code":4,"msg":5,"data":52},[53,58,62,66,71,76,81,84,88,91,94],{"id":21,"doc_module":4,"doc_module_name":54,"category_name":55,"show_sort_weight":56,"slug":57},"Document","Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":54,"category_name":59,"show_sort_weight":60,"slug":61},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":54,"category_name":63,"show_sort_weight":64,"slug":65},"Exam",70,"exam",{"id":67,"doc_module":4,"doc_module_name":54,"category_name":68,"show_sort_weight":69,"slug":70},5,"Comic",60,"comic",{"id":72,"doc_module":4,"doc_module_name":54,"category_name":73,"show_sort_weight":74,"slug":75},6,"Technology",50,"technology",{"id":77,"doc_module":4,"doc_module_name":54,"category_name":78,"show_sort_weight":79,"slug":80},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":54,"category_name":12,"show_sort_weight":82,"slug":83},30,"research-report",{"id":22,"doc_module":4,"doc_module_name":54,"category_name":85,"show_sort_weight":86,"slug":87},"Religion & Spirituality",20,"religion-spirituality",{"id":86,"doc_module":4,"doc_module_name":54,"category_name":89,"show_sort_weight":86,"slug":90},"World Cup","world-cup",{"id":20,"doc_module":4,"doc_module_name":54,"category_name":92,"show_sort_weight":20,"slug":93},"Lifestyle","lifestyle",{"id":95,"doc_module":4,"doc_module_name":54,"category_name":96,"show_sort_weight":67,"slug":97},19,"General","general",{"code":4,"msg":99,"data":100},"ok",{"site_id":25,"language":24,"slug":101,"title":13,"keywords":102,"description":14,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"home-based-supervised-exercise-on-metastatic-cancer-patients-receiving-oral-targeted-therapy-the-afsosunicancer-qualior-randomized-phase-2-study","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":54,"@type":111,"position":38},"https://docshare.wps.com/document/",{"item":115,"name":12,"@type":111,"position":43},"https://docshare.wps.com/document/research-report/",{"item":117,"name":13,"@type":111,"position":31},"https://docshare.wps.com/document/home-based-supervised-exercise-on-metastatic-cancer-patients-receiving-oral-targeted-therapy-the-afsosunicancer-qualior-randomized-phase-2-study/346349/",{"url":117,"name":13,"@type":119,"image":120,"author":125,"headline":13,"publisher":127,"fileFormat":130,"inLanguage":24,"description":14,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/home-based-supervised-exercise-on-metastatic-cancer-patients-receiving-oral-targeted-therapy-the-afsosunicancer-qualior-randomized-phase-2-study/346349.png","ImageObject",300,407,{"name":9,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":135,"interactionType":136,"userInteractionCount":20},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What was the primary endpoint in the QUALIOR phase 2 study?","Question",{"text":145,"@type":146},"Feasibility was defined as the proportion of patients who performed at least 50% of the theoretically planned sessions in the SPEP arm.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How were participants assigned in the trial?",{"text":150,"@type":146},"Patients with metastatic cancers receiving oral targeted therapies were randomized 2:1 to either a 3-month home-based SPEP with an in-home coach or adapted physical exercises recommended via a booklet.",{"name":152,"@type":143,"acceptedAnswer":153},"What outcomes were used to assess fatigue and pain?",{"text":154,"@type":146},"Fatigue and pain were evaluated using visual analogue scales (VAS) during the program.","https://schema.org",{"og:url":117,"og:type":157,"og:title":13,"og:site_name":128,"og:description":14},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":7,"site_id":25},1790113328]